SPY752.51 QQQ678.22 BTC/USD74,574.01−0.91%DIA523.41 GLD377.85 TLT81.84

Premium Services

Biote Corp

BTMDNASDAQ

Trade with Public

Trade with Public

Price data is not available

Overview News Earnings ForecastPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Biote (BTMD) Stock Price Target 2026

The average analyst price target for Biote is $5.17, 389.6% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $1.50 to $9. The latest change came on Aug 10, 2026, when B. Riley Securities lowered its price target on Biote from $2 to $1.50 and kept a Neutral rating.

The Average Analyst Price Target for Biote is $5.17.

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$5.17Upside to Avg. PT+389.6%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Biote Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$2→$2
Aug 7, 2026	TD Cowen	Jonna Kim	PT Cut	Buy	$3→$2
Apr 16, 2026	Truist Securities	Gregory Fraser	PT Cut	Buy	$5→$4
Mar 12, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$3→$2
Mar 12, 2026	TD Cowen	Jonna Kim	PT Cut	Buy	$3→$3
Aug 7, 2025	B. Riley Securities	Jeff Van Sinderen	Downgrade	Buy→Neutral	$8→$4
Mar 13, 2025	Craig-Hallum	Alex Fuhrman	PT Cut	Buy	$12→$8
Dec 16, 2024	Craig-Hallum	Alex Fuhrman	Initiate	Buy	$12
Mar 13, 2024	Roth MKM	George Kelly	PT Raise	Buy	$8→$9
Feb 20, 2024	B. Riley Securities	Jeff Van Sinderen	Initiate	Buy	$9
Feb 1, 2024	Jefferies	Kaumil Gajrawala	Initiate	Buy	$7
Jan 18, 2024	Truist Securities	Gregory Fraser	PT Cut	Buy	$10→$9
Jan 18, 2024	Roth MKM	George Kelly	PT Cut	Buy	$8→$7

Analyst Ratings News

PRO
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $2 to $1.5.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2

TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $2.5 to $2.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Biote, Lowers Price Target to $4

Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $5 to $4.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $3 to $2.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2.5

TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $3 to $2.5.

Benzinga Newsdesk

PRO
B. Riley Securities Downgrades Biote to Neutral, Lowers Price Target to $4

B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target from $8 to $4.

Benzinga Newsdesk